Tag Waisman Center
The vaccine will target those most vulnerable to COVID-19 — namely, the elderly and those with health conditions that weaken their immune system. Phase 1 trials could begin in early 2021 and UW–Madison may be a trial site.
Adults with lower genetic risk for ADHD also reported, on average, higher IQs and educational attainments, shorter or no criminal records, lower body mass index (BMI), and lower rates of depression than adults with middle-to-high genetic risk for ADHD.
UW–Madison's Marsha Mailick led researchers from the Waisman Center and Marshfield Clinic in a study that employed machine learning to mine decades of electronic health records of nearly 20,000 individuals.
It’s not a cure for Down syndrome that Dave Witte and Cristina Delgadillo want for their 5-year-old daughter. But they would be happy if stem cell research at the Waisman Center reduces the complications faced by Olivia, who has had two heart surgeries and a stroke.
UW–Madison researchers have shown that mice making too much of a human protein called AT-1 show signs of early aging and premature death, which are also symptoms of the human disorder progeria.
A UW–Madison lab that makes proteins, antibodies and viruses has begun manufacturing a virus critical to experimental treatments for many genetic conditions.
Qiang Chang, a longstanding member of the University of Wisconsin–Madison Waisman Center’s leadership team, has been named the new director of the center following a nationwide search.
UW–Madison's Waisman Center is one of the nation’s premier hubs for research and clinical outreach on human development, developmental disability and neurodegenerative disease.
Waisman Center research into the molecular mysteries of Rett Syndrome may ultimately help an 8-year-old girl who suffers from the rare neurological disorder.
Promising results in the lab and in animal models could set the stage for developing a treatment for Alexander disease, a rare and usually fatal neurological disease with no known cure.